ASMB
ASMB
NASDAQ · Biotechnology

Assembly Biosciences Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks
$20.42
+0.42 (+2.10%)
As of Nov 7, 2:06 AM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 10 91%
Hold 1 9%
Sell 0 0%
Price Target
Analyst Price Target -46.5% upside
Low Target $9.01
Average Target $10.92
High Target $17.95
Current Price $20.42
Current
$20.42
Target
$10.92
$9.01 $10.92 avg $17.95
Scenario Analysis
Bear Case
$9.01
-55.9%
Low target
Base Case
$10.92
-46.5%
Avg target
Bull Case
$17.95
+-12.1%
High target
Risk/Reward
0.2x
Unfavorable
Price in Context
52-Week High
$39.71
-48.6% from high
52-Week Low
$19.20
+6.4% from low
Target vs 52W High
$10.92
-72.5% vs high
Next Earnings Report
Nov 9, 2026
1d
tomorrow
EPS Est: $-0.45
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -11.6%
AMGN
Amgen Inc
 Hold 42 43% $190.87 -58.5%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +117.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 82% $438.34 -19.9%
MRNA
Moderna Inc
 Hold 31 35% $149.45 -41.2%
REGN
Regeneron Pharmaceuticals
 Buy 37 70% $76.80 -91.5%
NTRA
Natera Inc
 Strong Buy 30 90% $142.91 -54.0%
RVMD
Revolution Medicines Inc
 Strong Buy 29 93% $114.11 -40.7%